More on PVLA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Palvella Therapeutics (NQ:PVLA)
Delayed: 120.30 -7.04 (5.53%)
Prev. Close $127.34  
Open$127.27 
52 Wk High$ 
52 Wk Low$ 
Day High$127.27 
Day Low$118.23 
P/E N/A  
EPS$ 
Volume182,060 

Friends, Peers and Foes (?): PI6, KRYS, 0ACX, ARQT, INCY (more...)

Oct 16, 2026 09:22 AM Raymond James reiterates strong buy on Palvella Therapeutics (PVLA)
Oct 16, 2026 03:10 AM William Blair Starts Palvella Therapeutics (PVLA) at Outperform
Oct 15, 2026 07:31 AM Palvella to present trial data at pediatric dermatology conference
Oct 15, 2026 07:30 AM Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference
Oct 14, 2026 07:14 PM Form 4 PALVELLA THERAPEUTICS, For: Oct 12 Filed by: JENKINS GEORGE M
Oct 13, 2026 05:00 PM Form 144 PALVELLA THERAPEUTICS, Filed by: JENKINS GEORGE M
Oct 13, 2026 07:30 AM Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Oct 12, 2026 07:30 AM Palvella presents clinical and claims data at dermatology conference
Oct 12, 2026 07:30 AM Palvella Therapeutics Announces Three Poster Presentations Highlighting New Data in Microcystic Lymphatic Malformations and DSAP at Fall Clinical Dermatology 2026
Oct 12, 2026 06:50 AM Palvella Therapeutics (PVLA) PT Lowered to $246 at H.C. Wainwright
View All Articles

Entities mentioned with PVLA

View All Entities